Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
- PMID: 9625023
- DOI: 10.1097/00007890-199805270-00017
Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
Abstract
Background: Recently, the use of megadoses of CD34+ hematopoietic progenitors has been reported to abrogate resistance to engraftment, thus overcoming major histocompatibility barriers in bone marrow transplantation in leukemia patients.
Methods: The ability of human CD34+ cells to possess potent tolerizing activity was studied by limiting dilution analysis of cytotoxic T lymphocyte (CTL) precursors (CTL-p) in human peripheral blood lymphocytes after addition of purified CD34+ cells.
Results: The addition of purified human CD34+ cells to primary mixed lymphocyte culture led to a marked reduction of antiallogeneic CTL-p frequency against stimulator cells of the same origin, compared with the response against cells of third-party origin. The CD34+ cells caused a marked inhibition of the CTL activity, when added at an equal number with the responder T cells, and they were still present after the mixed lymphocyte culture, which suggests that no significant killing of CD34+ cells had occurred. The tolerizing activity is abrogated by irradiation and requires cell contact. This pattern of tolerization most closely resembles what has been ascribed to veto cells in other systems. Phenotypic analysis of the purified CD34+ cells showed that they express MHC class I and class II antigens, but do not express costimulatory molecules of the B7 family.
Conclusions: It is possible, that CD34+ cells in the megadose transplants-perhaps by their inability to provide costimulatory molecules-are actively reducing the frequency of CTL-p directed against their antigens, and thereby help to overcome allogeneic rejection, and enhance their own engraftment.
Similar articles
-
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.Ann N Y Acad Sci. 2003 May;996:72-9. doi: 10.1111/j.1749-6632.2003.tb03235.x. Ann N Y Acad Sci. 2003. PMID: 12799285
-
T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.Bone Marrow Transplant. 1998 Jun;21(12):1183-91. doi: 10.1038/sj.bmt.1701259. Bone Marrow Transplant. 1998. PMID: 9674849
-
Crossing the HLA barriers.Blood Cells Mol Dis. 2004 Nov-Dec;33(3):206-10. doi: 10.1016/j.bcmd.2004.08.004. Blood Cells Mol Dis. 2004. PMID: 15528132 Review.
-
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells.Blood. 2002 Jun 1;99(11):4174-81. doi: 10.1182/blood.v99.11.4174. Blood. 2002. PMID: 12010823
-
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.Ann N Y Acad Sci. 2005 Jun;1044:70-83. doi: 10.1196/annals.1349.010. Ann N Y Acad Sci. 2005. PMID: 15958699 Review.
Cited by
-
GVHD Prophylaxis 2020.Front Immunol. 2021 Apr 7;12:605726. doi: 10.3389/fimmu.2021.605726. eCollection 2021. Front Immunol. 2021. PMID: 33897681 Free PMC article. Review.
-
The use of donor-derived veto cells in hematopoietic stem cell transplantation.Front Immunol. 2012 May 2;3:93. doi: 10.3389/fimmu.2012.00093. eCollection 2012. Front Immunol. 2012. PMID: 22566971 Free PMC article.
-
Lung Regeneration by Transplantation of Allogeneic Lung Progenitors Using a Safer Conditioning Regimen and Clinical-grade Reagents.Stem Cells Transl Med. 2022 Mar 17;11(2):178-188. doi: 10.1093/stcltm/szab016. Stem Cells Transl Med. 2022. PMID: 35298657 Free PMC article.
-
Microchimerism in promoting graft acceptance in clinical transplantation.Curr Opin Organ Transplant. 2011 Aug;16(4):345-52. doi: 10.1097/MOT.0b013e3283489a42. Curr Opin Organ Transplant. 2011. PMID: 21666474 Free PMC article. Review.
-
Megadose CD34+ hemopoietic stem cell transplantation for patients with high risk acute myeloid leukemia who have no HLA matched donor--a pilot study of a full haplotype mismatch transplantation.Korean J Intern Med. 2004 Dec;19(4):243-9. doi: 10.3904/kjim.2004.19.4.243. Korean J Intern Med. 2004. PMID: 15683113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials